Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02674633 · ClinicalTrials.gov registry record · NA

Software Treatment for Actively Reducing Severity of ADHD

A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Akili Interactive Labs.

Completed
Registry status
NA
Development phase
348
Enrollment target
20
Study locations

NCT02674633 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by Akili Interactive Labs. The registered enrollment target is 348 participants, roughly in line with the 338-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target. The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02674633, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by Akili Interactive Labs.

COMPLETED
Registry status
NA
Development phase
348 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the effects of videogame-like digital therapies on attentional functioning and symptoms in children diagnosed with ADHD.

Conditions Studied

Attention Deficit Disorder With Hyperactivity

Interventions

  • DEVICE AKL-T01
  • DEVICE AKL-T09

Study Locations (20)

California

  • Avida, Inc. - Newport Beach
  • University of California Davis MIND Institute - Sacramento
  • University of California, San Francisco - San Francisco

Florida

  • Meridien Research - Bradenton
  • Florida Clinical Research Center - Maitland

North Carolina

  • Duke Child and Family Study Center - Durham
  • The Neuropsychiatric Clinic at Carolina Partners - Raleigh

Texas

  • FutureSearch Trials - Dallas
  • Bayou City Research, Ltd - Houston

Washington

  • Northwest Clinical Research Center - Bellevue
  • Seattle Children's - Seattle

Alabama

  • Harmonex Neuroscience Research - Dothan

Arizona

  • Melmed Center - Scottsdale

Illinois

  • Capstone Clinical Research - Libertyville

Trial Details

FieldValue
Enrollment Target 348 participants
Start Date 2016-05
Est. Completion 2017-08-31
Phase NA

Sponsor

Akili Interactive Labs

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02674633

The ClinicalTrials.gov registry entry for NCT02674633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 348 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 338-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target. The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 2 interventions - of which AKL-T01 is the first listed.

NCT02674633 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, North Carolina.

Frequently Asked Questions

What is clinical trial NCT02674633 about?

NCT02674633 is a clinical study titled "Software Treatment for Actively Reducing Severity of ADHD". The purpose of this study is to evaluate the effects of videogame-like digital therapies on attentional functioning and symptoms in children diagnosed with ADHD.

What is the current status of trial NCT02674633?

This trial is currently completed. It is a NA study. The enrollment target is 348 participants. The study started on 2016-05. Estimated completion is 2017-08-31.

What conditions does trial NCT02674633 study?

This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.

What interventions are being tested in trial NCT02674633?

The interventions under investigation include: AKL-T01 (DEVICE), AKL-T09 (DEVICE).

Who is sponsoring clinical trial NCT02674633?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02674633 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Disorder With Hyperactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Disorder With Hyperactivity

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.